MITA Calls for Strengthened Enforcement of Medical Device Remanufacturing

The Medical Imaging & Technology Alliance (MITA) has written a letter that calls for the U.S. Food and Drug Administration’s (FDA) to strengthen its guidance on medical device remanufacturing and urged the agency to take the necessary steps to properly enforce the...

Perlin Named President of The Joint Commission

The Board of Commissioners of The Joint Commission have announced the appointment of Dr. Jonathan B. Perlin to lead The Joint Commission as its next President and CEO. The appointment is effective March 1, 2022. Widely known for his leadership in healthcare quality...

GE Healthcare Introduces New CT System

GE Healthcare has unveiled Revolution Ascend[i] with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to...

United Imaging uCT ATLAS Earns FDA Clearance

United Imaging has announced FDA clearance for the uCT ATLAS, the latest in the company’s computed tomography (CT) portfolio of scanners and the 25th FDA clearance for the company overall.

Delivering precision solutions for a changing world

Cardinal HealthChange has been the one constant in nuclear medicine from the beginning, with the steady arrival of new radiopharmaceuticals, new technologies and an evolving regulatory environment.

Today, as nuclear medicine expands rapidly beyond diagnostics and into novel therapies personalized for individual patients, there is greater complexity and an even faster rate of change.

Theranostics and precision health care hold much promise for improving patients’ lives, but nuclear medicine departments face challenges in adopting new theranostics and ensuring patient access. In this complex, rapidly changing industry, the experts at Cardinal Health Nuclear & Precision Health Solutions have been providing trusted advice and guidance for more than 40 years, helping nuclear medicine departments prepare for and embrace the future. For example:

  • Cardinal Health established the first-ever commercial centralized nuclear pharmacy in 1972;
  • Cardinal Health created the first nationwide radiopharmacy network in 1982;
  • Cardinal Health opened the first commercial positron emission tomography (PET) cyclotron in 1992;
  • Cardinal Health completed the purchase of LYMPHOSEEK in 2017.

Read more about what Cardinal Health is doing to advance nuclear medicine in this new white paper authored by Mike Pintek, senior vice president of Cardinal Health Nuclear & Precision Health Solutions.



Submit a Comment

Your email address will not be published. Required fields are marked *